The Mykito Chitosan Platform
Our technology platforms represent the cutting edge of non-animal chitosan innovation.
ChitoGene leverages
recombinantly engineered yeast to produce the highest-performing chitosan.
BioFoundry provides custom
manufacturing and formulation solutions for specialized applications.
EndoFree delivers ultra-low endotoxin chitosan
for sensitive medical and pharmaceutical use.
ChitoGene
Next Generation Chitosan for Maximum Performance
Recombinant Yeast Production
High Prefomrance
Consistent & Scalable
Sustainable & Vegan
Genetically engineered yeast produces chitosan chemically and functionally identical to animal derived chitosan without the impurities
Customizable MW, DDA, and functional properties for specialized applications
Reliable batch-to-batch reproducibility from R&D to industrial production with complete traceability.
Fully renewable, animal-free production process
ChitoGene represents the next generation of non-animal chitosan, combining synthetic
biology and proprietary fermentation to deliver a high-performing, consistent, and fully vegan
biomaterial for industries seeking innovation, safety, and sustainability.
Low Molecular Weight Chitosan
Sub-20 kDa precision for bioactivity and controlled release
Enhanced Solubility
Improved Bioactivty
Precise
Control
Batch Consistency
Soluble in water and and slightly alkali environments
Optimal antimicrovial activity
Narrow molecular weight distribution
Crucial for medical, pharmaceutical, and nutraceutical use
The Low molecular Weight (LMW) platform represents our commitment to performance. This innovation extends the power of chitosan beyond acidic environments.
Absorbable & Biocompatible (ABC) Chitosan
Medical grade biomaterial that supports the body's natural healing
Fully
Biocompatible
Controlled Degradation
Versatile Material Forms
Absorbable
Compatible with human tissues, minimizing inflammation or immune response
Degrades naturally into non-toxic components, eliminating needs for removal
Tunable resorption rates to match tissue healing requirements
Fibers, hydrogels, films, coatings, and sponges for medical applications
The ABC Chitosan Platform empowers innovators to develop safe, effective, and absorbable
medical solutions. By combining non-animal safety with tunable performance, ABC
Chitosan sets a new standard for next-generation wound care, surgical, and tissue
engineering materials
EndoFree Chitosan
Ultra-Low endotoxin platform for sensitive medical and pharmaceutical use
Ultra Low
Endotoxin
High Purity
Consistent
Quality
Scalable
Production
Engineered to achieve the lowest endotoxin levels possible for chitosan
Free from animal contaminants, allergens, and other impurities
Controlled MW, DDA, and functional performance across every batch
Available from research-grade to industrial-scale volumes
The EndoFree Chitosan Platform delivers ultra-low endotoxin, high-purity, and consistent
performance, empowering innovators to develop safe, reliable, and regulatory-ready products
across medical, pharmaceutical, and biotech applications.
BioFoundry
Vegan chitosan for a sustainable future
Supply
Security
Consistent
Quality
High Value
Focus
Sustainable
Production
Diversified feedstocks eliminates reliance on any single raw material
Certified feedstocks ensure consistent product.
Optimized for applications where performance and regulatory compliance are essential
Vegan chitosan from valorized industrial and agricultural feedstocks.
The BioFoundry platform delivers reliable, high-value chitsoan with consistent performance and secure supply, empowering innovators to develop products that meet both regulatory standards and market demands without compromise